4.7 Review

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

Related references

Note: Only part of the references are listed.
Letter Rheumatology

SARS CoV-2 infection among patients using immunomodulatory therapies

Kevin L. Winthrop et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Gastroenterology & Hepatology

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Jordi Colmenero et al.

Summary: This study revealed that liver transplant patients have a higher risk of contracting COVID-19, but their mortality rate is lower than the general population. Baseline immunosuppression containing mycophenolate was identified as an independent predictor of severe COVID-19, especially at higher doses.

JOURNAL OF HEPATOLOGY (2021)

Letter Medicine, General & Internal

Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients

K. Patel et al.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Immunology

Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the Net State of Immunosuppression

Matthew B. Roberts et al.

Summary: Successful solid organ transplantation requires meticulous attention to immunosuppression details, balancing rejection and infection risks. The state of immune suppression serves as a conceptual framework for infectious risk, with a lack of assays measuring immune function. Adjusting immunosuppression during infections is rarely studied, leading to management largely based on clinical experience.

CLINICAL INFECTIOUS DISEASES (2021)

Article Rheumatology

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

Jean W. Liew et al.

Summary: This manuscript provides a detailed description of the development of the Global Rheumatology Alliance registry in response to the COVID-19 pandemic for people living with rheumatic diseases. By utilizing online platforms and international collaboration, the registry was able to quickly establish and adapt to meet urgent research needs. The model of forming an international team able to function effectively in online environments for rapid deployment of a registry can be adapted for other disease states and future global collaborations.

RHEUMATOLOGY (2021)

Article Immunology

COVID-19 in solid organ transplant recipients: No difference in survival compared to general population

Matteo Rinaldi et al.

Summary: This study compared SOT recipients and non-SOT patients with COVID-19 and found that the 30-day mortality rate among SOT recipients was similar to non-SOT patients, but with higher rates of respiratory failure and superinfections.

TRANSPLANT INFECTIOUS DISEASE (2021)

Article Rheumatology

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Paul C. Cremer et al.

Summary: The trial evaluating the efficacy of mavrilimumab in COVID-19 patients with systemic hyperinflammation did not show a significant difference in the proportion of patients alive and off oxygen therapy at day 14. Larger trials are needed to further assess the potential benefits or harms of mavrilimumab therapy in this patient population.

LANCET RHEUMATOLOGY (2021)

Article Infectious Diseases

HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes

Konstantin S. Sharov

Summary: This study investigated the synergy between HIV infection and COVID-19, finding that HIV patients without ART may experience more pronounced T-cell exhaustion when infected with COVID-19. The research suggests that HIV infection without ART could lead to a more serious course of COVID-19.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic

Sunjae Bae et al.

Summary: During the COVID-19 pandemic, kidney transplant recipients in the United States significantly decreased the use of lymphocyte-depleting induction agents in favor of basiliximab and no induction, potentially leading to increased rejection rates with no clear reduction in posttransplant mortality.

TRANSPLANTATION (2021)

Article Medicine, General & Internal

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial

Olivier Hermine et al.

Summary: In this clinical trial of COVID-19 patients with pneumonia requiring oxygen support but not in the ICU, tocilizumab did not reduce WHO-CPS scores below 5 by day 4 but may have reduced the risk of needing noninvasive ventilation, mechanical ventilation, or death by day 14. There was no difference in mortality by day 28. Further studies are needed to confirm these preliminary results.

JAMA INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Carlo Salvarani et al.

Summary: This study evaluated the use of tocilizumab in hospitalized COVID-19 pneumonia patients and found no significant benefit compared to standard care. Further randomized clinical trials with blinded, placebo-controlled methods are needed to confirm these results and explore potential applications of tocilizumab in different stages of the disease.

JAMA INTERNAL MEDICINE (2021)

Article Surgery

COVID-19 severity in kidney transplant recipients is similar to non-transplant patients with similar comorbidities

Nathalie Chavarot et al.

Summary: This study aimed to compare the outcomes of kidney transplant recipients and non-transplant patients in terms of survival and severity of COVID-19. The findings suggest that the severity of COVID-19 in kidney transplant recipients is related to their associated comorbidities and not to chronic immunosuppression.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Rheumatology

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes

Rebecca Grainger et al.

Summary: This review discusses the risk of infection, outcomes, and risk factors for poor outcomes in patients with rheumatic disease in the context of COVID-19. It also explores data from other immune-mediated diseases, limitations of current research efforts, translation of knowledge into practice guidance, and future research agenda.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)

Article Oncology

Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project

Gerard C. Millen et al.

Summary: This study aimed to provide evidence on the incidence and outcomes of SARS-CoV-2 in children with cancer attending hospitals in the UK. The study found that children with cancer appear to have similar risk of severe SARS-CoV-2 infection compared to the general pediatric population, with an estimated incidence of 3% in this group. This supports the continued delivery of standard treatment for children with cancer during the pandemic.

BRITISH JOURNAL OF CANCER (2021)

Article Immunology

Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System

Kathleen M. Andersen et al.

Summary: For adults hospitalized with COVID-19 in one US health system, chronic use of immunosuppressive drugs was not associated with either worse or better clinical outcomes, including risk of mechanical ventilation, in-hospital mortality, and length of stay.

CLINICAL INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

Luca S. Belli et al.

Summary: Despite concerns, data from adult liver transplant recipients with COVID-19 infection in Europe shows that age over 70, diabetes, and chronic kidney disease are associated with increased risk of death, while the use of tacrolimus may improve survival rates in these patients.

GASTROENTEROLOGY (2021)

Article Virology

A U-shaped association between baseline neutrophil count and COVID-19-related mortality: A retrospective cohort study

Wei Fu et al.

Summary: This study found a U-shaped association between baseline neutrophil count (bNC) and mortality in patients with COVID-19 infection, with a safe range of bNC being 1.64-4.0 x 10(9)/L, which may assist in early risk stratification and medical decision-making.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Immunology

COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature

Mohammed A. Raja et al.

Summary: A systematic review and meta-analysis of SOT recipients with SARS-CoV-2 infection revealed a high hospital admission rate and mortality rate. Common symptoms included fever and cough, with the majority of recipients requiring hospital treatment. Use of immunosuppressive medications decreased, while treatments varied.

TRANSPLANTATION REVIEWS (2021)

Article Rheumatology

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3

Ted R. Mikuls et al.

Summary: Guidance on managing adult rheumatic disease during the COVID-19 pandemic was developed by a task force of rheumatologists and infectious disease specialists. Through collating clinical questions, generating an evidence report, and using a modified Delphi process, final guidance statements were approved and presented as a living document due to the rapidly evolving literature and low level of available evidence. These statements aim to promote optimal care during the current pandemic with updates anticipated in the future.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Cardiac & Cardiovascular Systems

COVID-19 in Heart Transplant Recipients A Multicenter Analysis of the Northern Italian Outbreak

Tomaso Bottio et al.

Summary: This study assessed the clinical course and outcomes of heart transplant recipients affected by COVID-19 in Northern Italy. The results showed higher hospitalization rates and mortality rates among infected heart transplant recipients compared to the general population, emphasizing the importance of immediate referral to specialized centers for this vulnerable population.

JACC-HEART FAILURE (2021)

Article Hematology

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

Akshay Sharma et al.

Summary: This study examined the characteristics and outcomes of HSCT recipients after developing COVID-19. It found that recipients of autologous and allogeneic HSCT who develop COVID-19 have poor overall survival rates. Factors such as age, sex, and time since transplantation were associated with higher risk of mortality in HSCT recipients.

LANCET HAEMATOLOGY (2021)

Article Immunology

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

Krishnan Bhaskaran et al.

Summary: This study found that people living with HIV in the UK are at a higher risk of COVID-19 mortality compared to those without HIV. Even after adjusting for age, sex, ethnicity, and a range of comorbidities, the elevated risk remained significant, especially among individuals of Black ethnicity. Targeted policies should be considered to address this increased risk in the evolving pandemic response.

LANCET HIV (2021)

Article Oncology

Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests

Peter van Dam et al.

Summary: The study found that COVID-19 is heavily impacting the screening, diagnosis, and treatment of cancer patients. Seroprevalence was low among cancer patients, and there were divergent results in antibody tests. The immune responses of cancer patients varied, with some showing poor humoral immune responses.

EUROPEAN JOURNAL OF CANCER (2021)

Article Hematology

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Yair Herishanu et al.

Summary: Patients with chronic lymphocytic leukemia have a significantly impaired antibody response to the BNT162b2 mRNA COVID-19 vaccine, which is influenced by disease activity and treatment.

BLOOD (2021)

Article Infectious Diseases

Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy

Chiara Dentone et al.

Summary: This study aimed to describe the cellular characteristics of bronchoalveolar lavage fluid (BALF) of COVID-19 patients requiring invasive mechanical ventilation, finding that the prominent cells in BALF were neutrophils and macrophages. The percentage of macrophages in BALF upon ICU admission correlated with higher ICU mortality.

BMC INFECTIOUS DISEASES (2021)

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas et al.

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Article Immunology

COVID-19 in Lung Transplant Recipients

Jonathan Messika et al.

Summary: The COVID-19 infection in the French cohort of lung transplant patients was severe, with most cases requiring hospitalization and a survival rate of 85.7%. Among the critically ill patients, invasive mechanical ventilation was required for over half, and thrombotic events occurred in 4 patients. Overweight was significantly associated with the risk of death.

TRANSPLANTATION (2021)

Article Oncology

Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy

Astha Thakkar et al.

Summary: The study found differential rates of SARS-CoV-2 IgG seroconversion in cancer patients based on specific cancer types and therapy modalities. Patients with hematological malignancies, those receiving anti-CD-20 antibody therapy, and stem cell transplant patients had significantly lower seroconversion rates, while patients receiving immunotherapy, especially anti-PD-1/PD-L1 monoclonal antibodies, showed 100% seroconversion rates. These findings have implications for clinical monitoring and vaccination strategies to combat the COVID-19 pandemic.

NATURE CANCER (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Article Pharmacology & Pharmacy

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Canrong Wu et al.

ACTA PHARMACEUTICA SINICA B (2020)

Article Surgery

COVID-19 in solid organ transplant recipients: A single-center case series from Spain

Mario Fernandez-Ruiz et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Marcus R. Pereira et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal

Hasan K. Siddiqi et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Article Cardiac & Cardiovascular Systems

Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019

Farhana Latif et al.

JAMA CARDIOLOGY (2020)

Letter Medicine, General & Internal

Covid-19 and Kidney Transplantation

Enver Akalin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Mild or Moderate Covid-19

Rajesh T. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Surgery

Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

Beatriz Rodriguez-Cubillo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

COVID-19 in lung transplant recipients: A single center case series from New York City

Meghan Aversa et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A case-control study

Zohra S. Chaudhry et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Rasmus Rivinius et al.

CLINICAL RESEARCH IN CARDIOLOGY (2020)

Review Rheumatology

Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases

Milena Gianfrancesco et al.

CURRENT OPINION IN RHEUMATOLOGY (2020)

Article Hematology

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

Alpana Waghmare et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Article Immunology

Comprehensive mapping of immune perturbations associated with severe COVID-19

Leticia Kuri-Cervantes et al.

SCIENCE IMMUNOLOGY (2020)

Article Immunology

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

Mark Roschewski et al.

SCIENCE IMMUNOLOGY (2020)

Review Critical Care Medicine

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Ian Huang et al.

JOURNAL OF INTENSIVE CARE (2020)

Article Surgery

Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study

Marcus R. Pereira et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States

Miklos Z. Molnar et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Surgery

Tocilizumab use in Kidney Transplant Patients with COVID-19

Hernando Trujillo et al.

CLINICAL TRANSPLANTATION (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19

Ho Yuen Frank Wong et al.

RADIOLOGY (2020)

Article Immunology

COVID‐19 in kidney transplant recipients: A multicenter experience in Istanbul

Erol Demir et al.

Transplant Infectious Disease (2020)

Article Medicine, General & Internal

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

Zelalem Temesgen et al.

MAYO CLINIC PROCEEDINGS (2020)

Article Biochemistry & Molecular Biology

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane Marie Del Valle et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Oncology

Risk factors and outcome of COVID-19 in patients with hematological malignancies

Jose Luis Pinana et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Article Medicine, Research & Experimental

Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Gunjan L. Shah et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Teresa Aydillo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, Research & Experimental

The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19

Philip C. Robinson et al.

Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Gwilym J. Webb et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Rheumatology

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Giovanni Guaraldi et al.

LANCET RHEUMATOLOGY (2020)

Article Public, Environmental & Occupational Health

The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective

Stephanie Shiau et al.

AIDS AND BEHAVIOR (2020)

Review Cardiac & Cardiovascular Systems

HIV infection and coronary heart disease: mechanisms and management

Priscilla Y. Hsue et al.

NATURE REVIEWS CARDIOLOGY (2019)

Review Microbiology

Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs

Michael G. Ison et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

Review Medicine, General & Internal

HIV-Associated Cancers and Related Diseases

Robert Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Editorial Material Biochemistry & Molecular Biology

NKG2A, a New Kid on the Immune Checkpoint Block

John B. Haanen et al.

Article Infectious Diseases

Non-infectious Pulmonary Diseases and HIV

M. Triplette et al.

CURRENT HIV/AIDS REPORTS (2016)

Article Immunology

Influenza Susceptibility, Severity, and Shedding in HIV-Infected Adults: A Review of the Literature

Anandi N. Sheth et al.

CLINICAL INFECTIOUS DISEASES (2011)